Sign in
4

Changes in Ownership

Enliven Therapeutics, Inc. Filed Acc 0001415889-24-013383

CHIEF OPERATING OFFICER sold 1,107 shares at $25.00 ($27,675)

  • CHIEF OPERATING OFFICER acquired 1,107 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Patel Anish CHIEF OPERATING OFFICER 2024-05-14 Option exercise 10b5-1 +1,107 $2.48 $2,745 1,107 D: show line 1 in the form
Patel Anish CHIEF OPERATING OFFICER 2024-05-14 Sale 10b5-1 −1,107 $25.00 $27,675 0 D: show line 2 in the form
Open-market sales · 1,107 sh · avg $25.00 · $27,675

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Patel Anish CHIEF OPERATING OFFICER 2024-05-14 Option exercise · Employee Stock Option (right to buy) 10b5-1 −1,107 54,475 D: show line 3 in the form
Loading xslF345X05/form4-05162024_110525.xml…